What is AXSM's five-year median EV/Sales?

13.3x. Half of AXSM's weekly readings since February 2024 were higher and half were lower. This page has 140 weekly readings, from Feb 19, 2024 to Oct 19, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares AXSM only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Axsome Therapeutics Inc (AXSM) valuation history

Health Care

$145.04

Latest weekly close · Market cap $7.5B

Historically low

As of Oct 24, 2026

AXSM's EV/Sales of 9.5x is the lowest of its weekly readings since February 2024.

Weekly EV/Sales since February 2024

EV/Sales each weekMiddle half of its readingsMedian 13.3×

Median: 13.3×
Low to high: 9.5×–18.3×
Versus median: -29%
History starts: February 2024

EV/Sales

<1stpercentile

of its weekly readings since February 2024

Historically low

Growth, last 12 months vs the year before

Revenue: +57%slowing
EPS: n/a

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends. EPS was not positive in this window, so it is left out.

PriceRevenue, last 12 months100 = first reading

EV/Sales at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

AXSM EV/Sales at each year-end
Year-end	EV/Sales	5-year percentile
Dec 29, 2025	15.7×	96
Dec 30, 2024	11.9×	14

Health Care peers on EV/Sales

Each percentile compares a stock with its own last five years.

Compare AXSM with peers

Health Care peers of AXSM on EV/Sales
Stock	EV/Sales	Versus its own history	5-year percentile
BMYBristol Myers Squibb	3.3×	Within its usual range	48
CORTCorcept Therapeutics Inc	11.9×	Above its usual range	86
ELANElanco Animal Health Inc	2.9×	Within its usual range	56
JAZZJazz Pharmaceuticals PLC	3.8×	Within its usual range	60
JNJJohnson & Johnson	6.9×	Historically high	97

Appears in

Sector: Health Care
Screens: Stocks with Low P/E Ratios and Steady Revenue Growth
Stocks Below Their 5-Year Median P/E
Stocks Near Their Lowest P/E Ratios in 5 Years

Screen Health Care stocks the same way

Research on AXSM

No articles about AXSM yet. How valuation percentiles work

Loading peers and related research…

About this history

What is AXSM's current EV/Sales?: AXSM's EV/Sales of 9.5x is the lowest of its weekly readings since February 2024.
What is AXSM's five-year median EV/Sales?: 13.3x. Half of AXSM's weekly readings since February 2024 were higher and half were lower. This page has 140 weekly readings, from Feb 19, 2024 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares AXSM only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.